Catalyst Wire Dossier Catalyst Wire Dossier

Stivarga (regorafenib)

regorafenib · Bayer
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Stivarga (regorafenib), covering 2025-11-19 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of Regorafenib as Maintenance Therapy [Phase 2]

See pricing